Foundation Medical Partners Welcomes Kevin Sharer as Partner
Sharer Brings Operational Expertise to Investment Team

ROWAYTON, CT - March 5, 2013 - Foundation Medical Partners, a national healthcare venture capital investment firm, today announced that Kevin Sharer has joined the team as a Partner. Mr. Sharer joins Foundation's healthcare investment team to assess and manage investments in the connected health and healthcare IT sectors.

Mr. Sharer has a long and successful track record in leadership, management, and governance roles in innovative, fast-growing companies. Most recently, he served as Chairman and CEO of Amgen, the world's largest biotechnology company. He was Amgen's CEO from 2000 through 2012 and served as its chairman since 2001. He was President and Chief Operating Officer of Amgen from 1992 to 2000 and was a director since 1992. Under Mr. Sharerıs leadership as CEO, Amgen successfully launched nine products and completed the biotechnology industryıs largest-ever acquisition. During Mr. Sharerıs tenure as CEO, Amgen grew its annual revenues from over $3 billion in 1999 to revenues approaching $16 billion in 2011. Mr. Sharer currently serves on the boards of Chevron and Northrop Grumman and previously was a director of 3M.

"Kevin has had a long affiliation with Foundation and we are excited to bring him on board. He has already been adding his operational expertise and strategic guidance to our portfolio companies," said Andrew Firlik, Managing Partner of Foundation Medical Partners. "In addition, his network in the healthcare corporate community is an important source of deal flow and resources to help build early stage companies."

Mr. Sharer joins the investment team at Foundation Medical Partners that includes partners Andrew Firlik, Lee Wrubel, and Ted Laufik. The firm actively manages over $200 million in venture capital targeted toward start-up and early-stage companies. Foundation has remained exclusively focused on the healthcare technology market since the firm was founded in 2001, with a current market capitalization of its healthcare investments totaling approximately $2.0 billion.

About Foundation Medical Partners
Foundation Medical Partners is a national venture capital investment firm formed in 2001 with the vision of bringing together cutting edge healthcare expertise with deep company building experience. Foundation specializes in early stage venture capital for healthcare technology companies. Foundation Medical Partners was an early, active venture investor in many companies that subsequently went public or were acquired in strategic transactions, such as AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT), Combinatorx (NASDAQ: ZLCS), Immunicon (NASDAQ: IMMC, later acquired by Johnson & Johnson), Northstar Neuroscience (NASDAQ: NSTR, later acquired by St. Jude Medical), and Visiogen (acquired by Abbott), as well as a portfolio of other market-leading privately held firms.

For press correspondence, please contact
Managing Partner
Foundation Medical Partners
105 Rowayton Avenue
Rowayton, CT 06853
telephone: 203.851.3913